Navigation Links
NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
Date:10/30/2007

p>

$1,536,432 and $1,086,747) 19,069,295 9,552,784

Sales, general, and administrative

(includes non-cash compensation

expense of $3,159,734 and $309,068) 15,753,703 6,871,138

Depreciation and amortization 2,608,472 527,192

Total operating costs and

expenses 37,431,470 16,951,114

Operating income 7,719,731 8,207,775

Other income (expense):

Interest expense (2,388,529) (599)

Interest income 745,719 875,391

Other, net (27,259) (19,801)

Change in fair value of redeemable

preferred stock conversion feature

Total other income (expense) (1,670,069) 854,991

Income before income taxes 6,049,662 9,062,766

Income tax expense 2,261,818 3,480,615

Net income 3,787,844 5,582,151

Redeemable preferred stock accretion

Income applicable to common stockholders $3,787,844 $5,582,151

Earnings per common share:

Basic $0.13 $0.19

Diluted $0.12 $0.18

Weighted averages of common shares

outstanding:

Basic 30,111,156 29,836,960

Diluted 31,170,449 30,760,414

NIGHTHAWK RADIOLOGY HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

Nine Months Ended September 30,

2007 2006
'/>"/>

SOURCE NightHawk Radiology Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Radiology advance points way to non-invasive brain cancer treatment
2. International Teleradiology: The Future Of Radiologic Diagnosis
3. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
4. President’s Address on the ‘Tele-Radiology’ Set Up of Krst
5. Kalam to Commission Indias First Tele-Radiology Network
6. Kalam Urges for Using Tele-radiology to Help Rural Poor
7. Radiology Workforce Shortage
8. Sweet corn releases antioxidants on cooking
9. An International Growth Standard For Childs Releases By WHO
10. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
11. Eli Lilly Releases Digital Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email: